Xencor
Patents, Design & Utilities
Last updated:
List of all Xencor patents 117 in total
| Status | Patent |
|---|---|
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 7 Sep 2025 Issue date: 8 Sep 2022 |
Grant | Utility: Heterodimeric Fc variants Filling date: 7 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND ICOS ANTIGEN BINDING DOMAINS Filling date: 7 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: ENGINEERED IL-2 Fc FUSION PROTEINS Filling date: 7 Sep 2025 Issue date: 7 Jul 2022 |
Grant | Utility: PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof Filling date: 7 Sep 2025 Issue date: 5 Jul 2022 |
Application | Utility: BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES Filling date: 7 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS Filling date: 7 Sep 2025 Issue date: 23 Jun 2022 |
Grant | Utility: Methods and compositions for inhibiting CD32B expressing cells in IGG4-related diseases Filling date: 7 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Methods of treating neurological diseases Filling date: 7 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: IL-12 heterodimeric Fc-fusion proteins Filling date: 7 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and CD38 Filling date: 7 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: CTLA4-IG immunoadhesins Filling date: 7 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS Filling date: 7 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND TGFbetaRII Filling date: 7 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28 Filling date: 7 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: Engineered IL-2 Fc fusion proteins Filling date: 7 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Bispecific and monospecific antibodies using novel anti-PD-1 sequences Filling date: 7 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: ANTI-CD28 COMPOSITIONS Filling date: 7 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND CD3 Filling date: 7 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 7 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Heterodimeric proteins Filling date: 7 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3 Filling date: 7 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: ANTI-CD28 COMPOSITIONS Filling date: 7 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: TARGETED HETERODIMERIC Fc FUSION PROTEINS CONTAINING IL-15 IL-15alpha AND ANTIGEN BINDING DOMAINS Filling date: 7 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: CTLA4-Ig immunoadhesins Filling date: 7 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS Filling date: 7 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: IL-15/IL-15RA HETERODIMERIC FC FUSION PROTEINS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Bispecific checkpoint inhibitor antibodies Filling date: 7 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Heterodimeric antibodies that bind somatostatin receptor 2 Filling date: 7 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 7 Sep 2025 Issue date: 18 Jan 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 7 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Fc variants with altered binding to FcRn Filling date: 7 Sep 2025 Issue date: 14 Dec 2021 |
Application | Utility: TARGETED IL-12 HETERODIMERIC FC-FUSION PROTEINS Filling date: 7 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: Bispecific Antibodies That Bind to CD38 and CD3 Filling date: 7 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS Filling date: 7 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 7 Sep 2025 Issue date: 9 Sep 2021 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 7 Sep 2025 Issue date: 7 Sep 2021 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN Filling date: 7 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS Filling date: 7 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Modulation of T cells with bispecific antibodies and Fc fusions Filling date: 7 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains Filling date: 7 Sep 2025 Issue date: 10 Aug 2021 |
Application | Utility: NOVEL CTLA4-IG IMMUNOADHESINS Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PROPERTIES Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions Filling date: 7 Sep 2025 Issue date: 8 Jul 2021 |
Grant | Utility: Optimized antibody variable regions Filling date: 7 Sep 2025 Issue date: 6 Jul 2021 |
Application | Utility: Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE Filling date: 7 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: ANTI-STEAP1 ANTIGEN-BINDING PROTEIN Filling date: 7 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: HETERODIMERIC PROTEINS Filling date: 7 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE Filling date: 7 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: NOVEL HETERODIMERIC PROTEINS Filling date: 7 Sep 2025 Issue date: 3 Jun 2021 |
Showing 1 to 50 of 117 patents.